Fierce Pharma Biopharma News & Insights
WEB6 days ago · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
WEBThere were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...
The top 10 vaccine companies worldwide - Fierce Pharma
WEBWhat a difference five years—and a global pandemic—can make in reshaping an industry. When Fierce Pharma last published our rankings of the top vaccine players back in 2017, we highlighted the ...
The top 15 blockbuster patent expirations coming this decade
WEBLooking out over the next decade, some of the biggest drugs in the industry will tumble off the patent cliff, putting pharma giants in the hot seat as investors clamor for their next blockbuster.
Big Pharma Companies Ranked by Revenue 2022 - Fierce Pharma
WEBApr 18, 2023 · While a few companies continued to reap huge profits from COVID products in 2022, others benefited from a return to normalized business operations.
The top 10 best-paying places to work in biopharma
WEBPaying well is one way to lure job seekers in and keep existing talent happy, in biopharma and beyond. And while CEOs often catch the limelight for their multimillion-dollar paychecks, it is every ...
Verona earns FDA nod for potential blockbuster to treat COPD
WEBJun 26, 2024 · With FDA nod, Verona's Ohtuvayre is set to Jack up the COPD market. Thirteen years after his passing, Sir David Jack still looms as an innovative force in healthcare. Wednesday, when the FDA ...
WuXi shares jump after BIOSECURE Act's exclusion from defense …
WEBJun 12, 2024 · After months bouncing around at multi-year lows, WuXi Biologics’ stock jumped 14% in Hong Kong to a Wednesday high of 12.84 Hong Kong dollars. WuXi AppTec notched a 7% increase to reach 45.68 ...
FDA signs off on first engineered cell therapy for a solid tumor
WEBAug 2, 2024 · FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor. By Kevin Dunleavy Aug 2, 2024 8:56am. Adaptimmune soft tissue sarcoma T-cell therapy Galapagos ...
Biotech - Fierce Pharma
WEBSep 26, 2024 · Pfizer targets broad Talzenna label in prostate cancer. Pfizer hopes an overall survival showing could expand Talzenna's reach in mCRPC beyond those with HRR mutations. Angus Liu Oct 10, 2024 10 ...